(S (NP (NNP Histopathology)) (VP (VP (VBZ is) (NP (NP (DT a) (NN reflection)) (PP (IN of) (NP (DT the) (JJ molecular) (NNS changes))))) (CC and) (VP (VBZ provides) (NP (NP (JJ prognostic) (NNS phenotypes)) (VP (VBG representing) (NP (DT the) (NN disease) (NN progression)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD introduced) (NP (NP (NN feature) (NNS scores)) (VP (VBD generated) (PP (IN from) (NP (NN hematoxylin) (CC and) (NN eosin) (NN histology) (NNS images)))) (VP (VBN based) (PP (IN on) (NP (NP (JJ deep) (NN learning) (PRN (-LRB- -LRB-) (NNP DL) (-RRB- -RRB-)) (NNS models)) (VP (VBN developed) (PP (IN for) (NP (NN prostate) (NN pathology))))))))) (. .))
(S (NP (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT these) (NN feature) (NNS scores)) (VP (VP (VBD were) (ADJP (RB significantly) (JJ prognostic) (PP (IN for) (NP (NP (ADJP (NN time) (PP (TO to) (NP (NN event)))) (NNS endpoints)) (PRN (-LRB- -LRB-) (NP (NP (JJ biochemical) (NN recurrence)) (CC and) (NP (JJ cancer-specific) (NN survival))) (-RRB- -RRB-)))))) (CC and) (VP (VBD had) (ADVP (RB simultaneously)) (NP (NP (JJ molecular) (NN biologic) (NNS associations)) (PP (TO to) (NP (VB relevant) (NX (NX (JJ genomic) (NNS alterations)) (CC and) (NX (JJ molecular) (NNS subtypes))))))) (S (VP (VBG using) (NP (NP (ADJP (RB already) (VBN trained)) (NNP DL) (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB not) (VP (ADVP (RB previously)) (VP (VBN exposed) (PP (TO to) (NP (NP (DT the) (NNS datasets)) (PP (IN of) (NP (DT the) (JJ current) (NN study))))))))))))))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP (PRP we)) (VP (VBD discussed) (NP (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (JJ such) (NN feature) (NNS scores))) (S (VP (TO to) (VP (VB improve) (NP (DT the) (JJ current) (NN tumor) (NN grading) (NN system)))))) (CC and) (NP (NP (DT the) (NNS challenges)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (NN tumor) (NN heterogeneity)) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ prognostic) (NNS models))) (PP (IN from) (NP (NN histology) (NNS images))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS findings)) (VP (IN uncover) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NP (NN feature) (NNS scores)) (PP (IN from) (NP (NN histology) (NNS images))))) (PP (PP (IN as) (NP (NP (JJ digital) (NNS biomarkers)) (PP (IN in) (NP (NN precision) (NN medicine))))) (CC and) (PP (IN as) (NP (NP (DT an) (VBG expanding) (NN utility)) (PP (IN for) (NP (JJ digital) (NN pathology)))))))) (. .))
